In 2013 the US Food and Drug Administration (FDA) issued recommendations and guidance
on developing drugs for treatment of skin infection using a new definition of acute bacterial …

Complicated skin and soft tissue infections (cSSTIs) represent the severe form of infectious
disease that involves deeper soft tissues. Involvement of methicillin-resistant …

Background: Previous evidence-based guidelines on the management of intra-abdominal
infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and …

为指导基层狂犬病预防控制工作, 尤其是暴露后的预防处置及降低死亡, 中国CDC 组织专家,
参考WHO 和美国CDC 相关技术指南, 以及国内外最新研究进展, 制定了《 狂犬病预防控制技术 …

This review is the result of discussions that took place at the 5th MRSA Working Group
Consensus Meeting and explores the possible treatment options available for different types …

The transmission between community-associated (CA-) and healthcare-associated (HA-)
methicillin-resistant Staphylococcus aureus (MRSA) has increased the challenge of infection …

Staphylococcus aureus causes acute and chronic infections resulting in significant
morbidity. Urease, an enzyme that generates NH3 and CO2 from urea, is key to pH …

Skin and soft tissue infections (SSTIs) are among the most common infections worldwide.
They range in severity from minor, self-limiting, superficial infections to life-threatening …

Skin and soft-tissue infections (SSTIs) are among the most common bacterial infections,
posing considerable diagnostic and therapeutic challenges. Fourteen members of the Italian …

Methicillin-resistant Staphylococcus aureus (MRSA) has become the leading cause of skin
and soft tissue infections (SSTIs). Biofilm production further complicates patient treatment …